Founded in Toronto in 2012 by cancer-imaging researcher Dr. Ralph DaCosta, MolecuLight develops handheld medical imaging devices for point-of-care wound assessment. Its MolecuLight i:X and DX systems use fluorescence imaging to help clinicians locate elevated bacterial loads and digitally measure wounds, with DX also providing non-contact thermal imaging. The privately owned company operates under an ISO 13485:2016 quality management system and has FDA-cleared devices.
ISO 13485:2016 Quality Management System
SOC 2 Type 1 Accreditation
Compliance program
FDA Clearance
Registration
Health Canada Approval
Registration
CE Marking
Registration
CE
Quality certification